BÜHLMANN Quantum Blue® Anti-Adalimumab CE IVD rapid test available now! - BÜHLMANN Laboratories is proud to announce the addition of the CE marked Quantum Blue® Anti-Adalimumab to our TDM rapid test portfolio.
Quantum Blue® Infliximab posters at virtual AACC 2020 - At the virtual AACC 2020 BÜHLMANN had the great opportunity to present two posters about the Quantum Blue® Infliximab.
COVID-19 impact on IBD centers: IBDoc® success story and surveys - Inflammatory Bowel Disease (IBD) centers dealing with patients having chronic conditions had to quickly adapt to use home monitoring tools during the COVID-19 pandemic, including IBDoc®, as a mean to safely test fecal calprotectin.

DDW 2021

Date: 21 – 23 May 2021
Location: virtual event

Digestive Disease Week 2021

WCPGHAN 2021

Date: 2 – 5 June 2021
Location: Vienna, Austria

6th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition

ECCO 2021

Date: 7 – 10 July 2021
Location: Copenhagen, Denmark

Inflammatory Bowel Diseases – 16th Congress of ECCO

AMLI 2021

Date: 13 – 16 August 2021
Location: Austin, TX, USA

34th Annual Scientific Meeting of the Association of Medical Laboratory Immunologists